Mira Pharmaceuticals, Inc. Common Stock reports a Return on Equity (ROE) of -104.92%.

What is MIRA's dividend yield?

Mira Pharmaceuticals, Inc. Common Stock offers a dividend yield of 0.00%.

What is MIRA's Quality Score?

Our AI rates MIRA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MIRA?

Our AI Timing Score for MIRA is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MIRA belong to?

Mira Pharmaceuticals, Inc. Common Stock is classified under the Healthcare >> Drug Manufacturers - General sector on the NASDAQ exchange

Mira Pharmaceuticals, Inc. (MIRA) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

MIRA AI Analysis Summary

Our AI summary for MIRA: Mira Pharmaceuticals, Inc. Common Stock (NASDAQ), Healthcare >> Drug Manufacturers - General sector. The stock currently trades at a P/E of 0.00, ROE of -104.92%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MIRA

Mira Pharmaceuticals, Inc. Common Stock

USD 0.79

-0.02 (-2.98%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-104.9%

ROE

-103.7%

ROA

0.00%

Div Yield

MIRA PHARMACEUTICALS, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.79 Price -0.02 (-2.98%) Day Change	NEWS SCORE: 94

MIRA, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.79
PBV / Sector	3.67 / 2.68
Earning Per Share	-0.23

PE / Sector	N/A / 27.65
PEG or PE/Growth / Sector	N/A / 0.28
Average 1M Daily Value	0.05 M GREAT
Average 1W Daily Value	0.04 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 17.30
NPM Average (%) / Sector	N/A / 17.60
NPM Change Average (%) / Sector	N/A / 92.67
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-103.65 / 8.73
ROA Average (%) / Sector	-306.38 / 8.56
ROA Change Average (%) / Sector	-28.68 / 94.23
ROE (%) / Sector	-104.92 / 26.78
ROE Average (%) / Sector	69.50 / 13.05 GREAT
ROE Change Average (%) / Sector	-40.07 / 96.64
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 2.40
Dividend Average (%) / Sector	N/A / 3.39
Dividend Change Average (%) / Sector	N/A / 4.92

Registration Details

Analyze Date	2026-08-01 08:00:10
Symbol	MIRA
Name	MIRA PHARMACEUTICALS, INC. COMMON STOCK
Sector	Healthcare >> Drug Manufacturers - General
Market	NASDAQ
Listed Shares	42.02 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	34.30 / 256,404.20

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1200 Brickell Avenue, Miami, FL, United States, 33131

Phone: 786 432 9792

Website: https://mirapharmaceuticals.com

Sector: Healthcare >> Drug Manufacturers - General

Description: MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.